Genome Editing Market is Growing at a High CAGR by 2025

1. Global Genome Editing Market to 2025 www.theinsightpartners.com GENOME EDITING MARKET To 2025 Global Analysis and Forecasts By Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), and Others), Application Global Analysis and Forecasts By Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), and Others), Application (Genetic Eng (Genetic Engineering, Cell Line Engineering and Others), End User (Biotechnology & Pharmaceutical Companies, Contract ineering, Cell Line Engineering and Others), End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes) and Geography Research Organizations (CROs), and Academic & Government Research Institutes) and Geography 1

2. Global Genome Editing Market to 2025 www.theinsightpartners.com According to a new market research study titled ‘Genome Editing Market Genome Editing Market to 2025 - Global Analysis and Forecasts by Technology, Application and End User, the global genome editing market was valued at US$ 3,210.1 Mn in 2017 and is estimated to reach US$ 10,691.0 Mn by 2025. The report highlights the trends prevalent in the global genome editing market and the factors driving the market along with the restraints that are impacting its growth. The technology segment is divided into transcription activator-like effector nucleases (TALENS), clustered regularly interspaced short palindromic repeats (CRISPR), zinc finger nucleases (ZFNs), antisense RNA and others. Among the technology segment the CRISPR holds the largest market share whereas, the TALENs is the fastest growing segment. The dominancy is expected to be continued by the CRISPR owing to the advantages offered, elimination of invading genetic material and enables the organisms to respond the changes. In addition, CRISPR-Cas9 is faster, cheaper and more accurate than the other technologies of DNA editing and is used for the wide applications. It is considered to be the simplest, most versatile and precise method of genetic manipulation. Moreover, the CRISPR technology is utilized in every field of the genome editing. The market for genome editing by the technology segment is expected to reach US$ 6,132.3 million by 2025 in the forecasted period. CRISPR segment has the highest market share in 2017, contributing a market share of 53.6% and is expected to retain its dominance during the forecast period from 2018 to 2025 to account for a market share of 57.4% of the overall revenue generated in 2025. The report includes the driving factors such as increase in funding for the genome editing, rising prevalence of the genetic disorders, rise in the advancements for the genome editing technology and rise in the production of the genetically modified crops. The opportunities for the market is analyzed as the emerging markets for precision and regenerative medicines. The usage of CRISOR Cas9 technology is the current for the genome editing market. Key industry players operating in the field of genome editing across the globe include Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., Thermo Fisher Scientific Inc., GenScript, Lonza, Horizon Discovery Group plc, Sangamo Therapeutics, Inc., New England Biolabs, Editas Medicine, Merck KGaA. The report segments the global genome editing market as follows: Global Genome Editing Market Global Genome Editing Market – – By Technology By Technology TALENS CRISPR ZFN Others Global Genome Editing Market Global Genome Editing Market – – By Application By Application Genetic Engineering Animal Genetic Engineering Plant Genetic Engineering Cell Line Engineering 2

3. Global Genome Editing Market to 2025 www.theinsightpartners.com Others Global Genome Editing Market Global Genome Editing Market – – By End User By End User Biotechnology & Pharmaceutical Companies Contract Research Organization (CROs) Academic & Government Research Institutes Global Genome Editing Market Global Genome Editing Market – – By Geography By Geography North America U.S. Canada Mexico Europe UK Germany France Asia Pacific (APAC) Japan China India Middle East & Africa (MEA) South Africa Saudi Arabia UAE South & Central America (SCAM) Brazil Check Research Sample Check Research Sample at at https://www.theinsightpar https://www.theinsightpartners.com/sample/TIPHE100000853 tners.com/sample/TIPHE100000853 3

4. Global Genome Editing Market to 2025 www.theinsightpartners.com ABOUT US The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Technology, Media, and Telecommunication. Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis. Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, technology, products, and services etc., which helps our clients to gain a deeper analytical understanding of various research topics. CONTACT US If you have any queries about this report or would like further information, please contact us: North America: +1 646 491 9876 Email: sales@theinsightpartners.com DISCLAIMER All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”. The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the findings, conclusions, and recommendations that “The Insight Partners” delivers will be based on information gathered in good faith from primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such, “The Insight Partners” can accept no liability whatsoever for actions taken based on any information that may subsequently prove to be incorrect. 4